Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454)- R20 - Effective October 1, 2026

Date Posted: November 5, 2026

This Billing and Coding Article has been revised under contract numbers: 02101 (AK), 02201 (ID), 02301 (OR), 02401 (WA), 03101 (AZ), 03201 (MT), 03301 (ND), 03401 (SD), 03501 (UT), and 03601 (WY).

Effective Date: Multiple dates

Summary of Changes:

Under CPT/HCPCS Codes Group 1: Codes added 0688U and 0689U. This revision is due to the 2026 Q4 CPT/HCPCS Code Update and is effective 10/01/2026.

Under Article Text subheading Additional Test-specific Indications, Limitations and Instructions revised third sentence to add "RaDaR". This revision is due to a new covered test that has successfully completed a TA and is effective 4/9/2026.

Visit the Noridian Molecular Diagnostic Services webpage to view the Active MolDX LCDs or access it via the CMS MCD.

Last Updated Nov 05 , 2026